Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8

specific

Stage II includes: T1, N0, M0, G2, G3. T1: Tumor measuring 5 cm or less in greatest dimension. N0: No regional lymph node metastasis or unknown lymph node status. M0: No distant metastasis. G2: Total differentiation, mitotic count and necrosis score of 4 or 5. G3: Total differentiation, mitotic count and necrosis score of 6, 7, or 8. (AJCC 8th ed.)

51

Centers

71

Active Trials

Cancer Funding

Top Centers for Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8(51)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
64.7
2
NCI Comprehensive
Active Research Program
64.7
3
NCI Comprehensive
Active Research Program
64.7
4
NCI Comprehensive
Active Research Program
64.7
564.7
6
NCI Comprehensive
Active Research Program
64.7
7
NCI Comprehensive
Active Research Program
64.7
8
NCI Comprehensive
Active Research Program
64.7
9
NCI Comprehensive
Active Research Program
64.7
10
NCI Comprehensive
Active Research Program
64.7
11
Active Research Program
64.7
12
NCI Comprehensive
Active Research Program
64.7
13
Active Research Program
64.7
14
NCI Clinical
Active Research Program
64.7
15
Active Research Program
64.7
16
NCI Clinical
Active Research Program
64.7
17
Active Research Program
64.7
18
Active Research Program
64.7
19
Active Research Program
64.7
20
Active Research Program
64.7
21
NCI Comprehensive
Active Research Program
42.2
22
NCI Comprehensive
Active Research Program
42.2
23
NCI Comprehensive
Active Research Program
42.2
24
NCI Comprehensive
Active Research Program
42.2
25
NCI Comprehensive
Active Research Program
42.2
26
NCI Comprehensive
Active Research Program
42.2
27
NCI Comprehensive
Active Research Program
42.2
28
NCI Comprehensive
Active Research Program
42.2
29
NCI Comprehensive
Active Research Program
42.2
30
NCI Comprehensive
Active Research Program
42.2
31
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
42.2
32
NCI Comprehensive
Active Research Program
42.2
33
NCI Comprehensive
Active Research Program
42.2
34
NCI Comprehensive
Active Research Program
42.2
35
NCI Comprehensive
Active Research Program
42.2
36
NCI Clinical
Active Research Program
42.2
37
NCI Comprehensive
Active Research Program
42.2
38
NCI Comprehensive
Active Research Program
42.2
39
NCI Clinical
Active Research Program
42.2
40
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
42.2
41
NCI Comprehensive
Active Research Program
42.2
42
NCI Comprehensive
Active Research Program
42.2
43
NCI Comprehensive
Active Research Program
42.2
44
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
42.2
4542.2
46
Active Research Program
42.2
47
Active Research Program
42.2
4842.2
49
Active Research Program
42.2
50
Active Research Program
42.2
51
Active Research Program
42.2

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →